From: Eva Dubin < Sent: Friday, October 20, 2017 4:22 AM To: jeffrey E. Subject: Re: Cephalexin is Keflex Please note, my email address has changed to <mailto On Oct 20, 2017, at 12:05 AM, jeffrey E. <jeevacation@gmail.com <mailto:jeevacation@gmail.com> wrote: dont have keflex how about cephlaxin. On Fri, Oct 20, 2017 at 5:55 AM, Eva Dubin < <mailto > wrote: You? Where are you? Just soak it and take Keflex... Otherwise I have a bunch of names I can send you tomorrow... Please note, my email address has changed to <mailto On Oct 19, 2017, at 11:36 PM, "jeevacation@gmail.com <mailto:jeevacation@gmail.com> " <jeevacation@gmail.com <mailto:jeevacation@gmail.com» wrote: ingrown toenail , got a bit infected. foot doctor? today? who? please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacation@gmail.com> , and EFTA_R1_01438899 EFTA02401882 destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeevacation@gmail.com> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved 2 EFTA_R1_01438900 EFTA02401883